DZ1926A1 - Formulations pharmaceutiques. - Google Patents

Formulations pharmaceutiques.

Info

Publication number
DZ1926A1
DZ1926A1 DZ950107A DZ950107A DZ1926A1 DZ 1926 A1 DZ1926 A1 DZ 1926A1 DZ 950107 A DZ950107 A DZ 950107A DZ 950107 A DZ950107 A DZ 950107A DZ 1926 A1 DZ1926 A1 DZ 1926A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
DZ950107A
Other languages
English (en)
Original Assignee
Smithkline Beckman P L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beckman P L C filed Critical Smithkline Beckman P L C
Application granted granted Critical
Publication of DZ1926A1 publication Critical patent/DZ1926A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DZ950107A 1994-09-03 1995-08-02 Formulations pharmaceutiques. DZ1926A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
DZ1926A1 true DZ1926A1 (fr) 2002-02-17

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ950107A DZ1926A1 (fr) 1994-09-03 1995-08-02 Formulations pharmaceutiques.

Country Status (8)

Country Link
EP (1) EP0782443A1 (fr)
JP (1) JPH10505595A (fr)
AU (1) AU3471995A (fr)
DZ (1) DZ1926A1 (fr)
IL (1) IL115125A0 (fr)
MA (1) MA23663A1 (fr)
TR (1) TR199501082A2 (fr)
WO (1) WO1996007408A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1093812A3 (fr) 1995-09-07 2001-06-06 SmithKline Beecham Corporation Composition pharmaceutique contenant de l'amoxicilline et du clavulanate
IL131201A (en) * 1997-02-14 2005-06-19 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxycillin and clavulanate
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
KR100661413B1 (ko) * 1998-07-06 2006-12-27 나노박 오와이 나노박테리아 박멸 방법
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
EP2575782A2 (fr) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulations effervescentes comprenant de la céphalosporine et de l'acide clavulcanique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861607D1 (en) * 1977-11-26 1982-03-11 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
AU5863894A (en) * 1993-01-22 1994-08-15 Smithkline Beecham Plc Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics

Also Published As

Publication number Publication date
EP0782443A1 (fr) 1997-07-09
IL115125A0 (en) 1995-12-31
TR199501082A2 (tr) 1996-06-21
AU3471995A (en) 1996-03-27
MA23663A1 (fr) 1996-04-01
JPH10505595A (ja) 1998-06-02
WO1996007408A1 (fr) 1996-03-14

Similar Documents

Publication Publication Date Title
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
TR199901077A3 (tr) Ispençiyari formülasyonlar.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69530325D1 (de) Aerosol-arzneiformulierungen
FI971279A0 (fi) Lääkkeitä
DE69525148D1 (de) Pharmazeutische formulierung
ID24654A (id) Formulasi farmasi omeprazola
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
BR9610396A (pt) Formulação farmacêutica
EP0850057A4 (fr) Composes pharmaceutiques
DZ1559A1 (fr) Compositions pharmaceutiques.
TR199501082A2 (tr) Farmasötik formülasyonlar.
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
MX9200532A (es) Agente farmaceuticos.
EP0923564A4 (fr) Composes pharmaceutiques
FI973230L (fi) Uusi farmaseuttinen formulaatio
MA26604A1 (fr) Compositions pharmaceutiques.
FI951155A7 (fi) Farmaseuttinen valmiste
FI923371A0 (fi) En farmaceutisk formulation.
TR199601018A1 (tr) Farmasötik bilesikler.
FI961364L (fi) Lääkeainekoostumus